4.1 Article

Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab

期刊

JOURNAL OF NEUROVIROLOGY
卷 26, 期 6, 页码 961-963

出版社

SPRINGER
DOI: 10.1007/s13365-020-00899-0

关键词

Progressive multifocal leukoencephalopathy; Pembrolizumab; JC virus; Haematologic malignancies

向作者/读者索取更多资源

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease affecting the central nervous system as a result of reactivation of the John Cunningham (JC) polyomavirus and occurs almost exclusively in immunosuppressed individuals. The disease course of PML is variable but usually progressive and often fatal. Treatment is predominantly focused on immune restoration, although this is difficult to do outside of human immunodeficiency virus-associated PML. A recent case series demonstrated a potential role for programmed cell death protein 1 (PD-1) inhibitors, such as pembrolizumab, to contain and/or clear JC virus. Herein, we discuss the first reported Australian case of a 61-year-old female with PML secondary to chemoimmunotherapy demonstrating complete clearance of JC virus as well as clinical and radiological stabilisation following pembrolizumab treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据